Predictmedix Stock News

Predictmedix Inc, a provider of health screening solutions powered by artificial intelligence (AI), has announced the expansion of its non-invasive impairment detection technology for vertical-specifi

 Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening  Toronto, Ontario - March 21, 2023 - InvestorsHub NewsWire -- Predictmedix Inc. ("Predictmedix" or the "Company") (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that the US Patent Office has granted a patent for its AI-powered technology (United St...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) announced that the US Patent Office has granted the company a patent (United States Patent Application Number: 16/892,369) for its artificial intelligence (AI

 Predictmedix Announces Production of AI-Powered Mobile Application to Detect Impairment from Alcohol and Cannabis Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix's screening to identify impairment takes less than 30 seconds  The mobile application, powered by AI algorithms currently being utilized in Safe Entry will be accompanied by a "mini" multi-spectral imaging camera resulting in a portable non-...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced the production of its AI-Powered mobile app in conjunction with a portable multi-spectral imaging camera to non-invasively detect impairment fro

 Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix's Safe Entry for regulatory approval listed as a 'Medical Device' Medical device classification allows Predictmedix to commercialize Safe Entry at scale in Indonesia Third-party clinical validation yet another milestone for Predictmedix's AI-Powered screen...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced the completion of a 1,600-person clinical study at a prominent University in Indonesia to validate the company's AI-powered non-invasive screen

Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector   DefSpace, a global platform for Defence, Space and Aerospace will lease four Safe Entry Stations over four-year term primarily utilizing Safe Entry's impairment detection screening   Each of the four Safe Entry Station's to generate $2500 per month in recurring revenue for an initial four-year term, approximating a total of $500,000  ...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced a purchase agreement with Defspace, an India-based global platform for defence, space and aerospace, for the company's Safe Entry's Fit for Duty

    Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare     Toronto, Ontario, February 15, 2023 -- InvestorsHub NewsWire -- Predictmedix Inc. ("Predictmedix" or the "Company") (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced pivotal clini...

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) said its AI-powered Safe Entry Stations, which accurately screen for various physiological conditions non-invasively, have received pivotal clinical validatio

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has raised C$612,500 through a placing with the proceeds set to support working capital. The artificial intelligence-powered rapid health screener, in a state

PredictMedix Inc. said it will be "hyper-focused" on commercialization throughout 2023 with plans to secure high-revenue recurring placements for workplaces in industries such as mining, manufacturi

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced the revenue-generating deployment of Safe Entry at LongArm Engineering's Odessa Texas facility, which will be secured by Predictmedix's lead res

Predictmedix Inc said it has closed the final tranche of its non-brokered private placement for gross proceeds of $80,000 which will be used for general operations, including business developments and